We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
IDBS ELN Powers World Class Preclinical Research at the UCT
News

IDBS ELN Powers World Class Preclinical Research at the UCT

IDBS ELN Powers World Class Preclinical Research at the UCT
News

IDBS ELN Powers World Class Preclinical Research at the UCT

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "IDBS ELN Powers World Class Preclinical Research at the UCT"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

IDBS has announced that the University of Cape Town (UCT) Drug Discovery and Development Centre, H3-D (http://www.h3-d.uct.ac.za/), is using the BioBook Electronic Laboratory Notebook (ELN) to store, manage and analyze its Drug Metabolism and Pharmacokinetic (DMPK) data.

Aligning itself with international standards in drug discovery, H3-D benefits from BioBook’s ability to consolidate assay results in one place, improving workflow and accelerating preclinical research.

“BioBook helps us undertake world class research from right here in South Africa. It is an exciting step for us as we are not only working faster but we are doing so without compromising on quality. Our confidence in our data continues to grow every day,” said Dr Nyaradzo T.L Chigorimbo-Tsikiwa, a postdoctoral fellow within H3-D.

Chigorimbo-Tsikiwa continued, “Having worked with BioBook previously, I’m confident in its abilities to provide us with the efficiency and traceability that we require in our fast moving environment.”

BioBook is currently being rolled out across H3-D. Users are able to track research projects and manage the large volumes of data associated with individual assays.

Analysis is completed within the system rather than relying on Microsoft Excel for data handling.

Working in this efficient way minimizes the risk of human error and enables H3-D to advance it’s drug discovery on a global scale with conviction in its research findings.

Neil Kipling, CEO and Founder of IDBS said, “The world’s leading academic institutions are now taking advantage of industrial informatics platforms like BioBook. Our ELN significantly improves workflow and boosts research productivity by up to 30%. It also makes collaboration easier and enables better decision making. This new relationship with UCT demonstrates our commitment to providing global academia with modern informatics technologies which can revolutionize academic R&D.”

BioBook is a flexible, automated solution which dramatically reduces time to market in late stage discovery, pharmacology and preclinical R&D.

It integrates with legacy data software such as laboratory information management systems (LIMS) and combines data imported from laboratory instruments to keep all research in one secure environment.

Advertisement